AU1795400A - Expression vectors comprising multiple shear stress responsive elements (ssre) and a gene of interest and methods of use thereof - Google Patents
Expression vectors comprising multiple shear stress responsive elements (ssre) and a gene of interest and methods of use thereofInfo
- Publication number
- AU1795400A AU1795400A AU17954/00A AU1795400A AU1795400A AU 1795400 A AU1795400 A AU 1795400A AU 17954/00 A AU17954/00 A AU 17954/00A AU 1795400 A AU1795400 A AU 1795400A AU 1795400 A AU1795400 A AU 1795400A
- Authority
- AU
- Australia
- Prior art keywords
- ssre
- gene
- interest
- methods
- expression vectors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000013604 expression vector Substances 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Obesity (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Physics & Mathematics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11386398P | 1998-12-24 | 1998-12-24 | |
US09/220,510 US6440726B1 (en) | 1998-12-24 | 1998-12-24 | Expression vectors comprising multiple shear stress responsive elements (SSRE) and methods of use for treating disorders related to vasculogenesis and/or angiogenesis in a shear stress environment |
US09220510 | 1998-12-24 | ||
US60113863 | 1998-12-24 | ||
PCT/IL1999/000702 WO2000039275A2 (en) | 1998-12-24 | 1999-12-23 | Multiple shear stress responsive elements (ssre) and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1795400A true AU1795400A (en) | 2000-07-31 |
Family
ID=26811564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU17954/00A Abandoned AU1795400A (en) | 1998-12-24 | 1999-12-23 | Expression vectors comprising multiple shear stress responsive elements (ssre) and a gene of interest and methods of use thereof |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1141266A4 (en) |
JP (1) | JP2002533113A (en) |
AU (1) | AU1795400A (en) |
WO (1) | WO2000039275A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002335040A1 (en) | 2001-10-16 | 2003-04-28 | Atherogenics, Inc. | Protection against oxidative stress and inflammation by a cytoprotective response element |
CN101678074B (en) * | 2007-03-22 | 2014-04-23 | 韩国加图立大学产学合作基金会 | Novel use of ec-sod and method for preparing thereof |
CN109371046A (en) * | 2018-09-29 | 2019-02-22 | 上海交通大学 | A kind of induction type oxin-antitoxin element for thermophilic microorganism genetic manipulation |
USD926199S1 (en) | 2019-05-17 | 2021-07-27 | Opsens, Inc. | Display screen or portion thereof with graphical user interface |
CN112656763B (en) * | 2020-12-29 | 2022-07-15 | 吉林大学 | Preparation method of drug-loaded nano-micelle based on shear force response |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5834306A (en) * | 1994-12-23 | 1998-11-10 | Sri International | Tissue specific hypoxia regulated therapeutic constructs |
US5968770A (en) * | 1995-02-10 | 1999-10-19 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target |
JP2001517081A (en) * | 1997-04-08 | 2001-10-02 | ザ ユナイテッド ステイツ オブ アメリカ アズ リプリゼンティッド バイ ザ アドミニストレイター オブ ザ ナショナル アエロノーティクス アンド スペイス アドミニストレイション(ナサ) | Production of functional proteins: balance between shear stress and gravity |
-
1999
- 1999-12-23 JP JP2000591168A patent/JP2002533113A/en active Pending
- 1999-12-23 WO PCT/IL1999/000702 patent/WO2000039275A2/en not_active Application Discontinuation
- 1999-12-23 EP EP99961261A patent/EP1141266A4/en not_active Withdrawn
- 1999-12-23 AU AU17954/00A patent/AU1795400A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2002533113A (en) | 2002-10-08 |
EP1141266A2 (en) | 2001-10-10 |
EP1141266A4 (en) | 2002-09-25 |
WO2000039275A3 (en) | 2000-10-26 |
WO2000039275A2 (en) | 2000-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7816398A (en) | Coordinating input of asynchronous data | |
AU4053699A (en) | Novel human genes and gene expression products | |
AU6039199A (en) | Useful properties of a bee venom protein and gene encoding same | |
AU7579998A (en) | Full field photoelastic stress analysis | |
AU7435296A (en) | Novel expression vectors and methods of use | |
AU6544598A (en) | Compositions and methods for analysis of nucleic acids | |
AU4187499A (en) | Human genes and gene expression products v | |
AU6952798A (en) | Hosel coupling assembly and method of using same | |
AU8169498A (en) | Backpack assembly and method of use | |
IL116984A (en) | Multiple FIFO array and method of construction thereof | |
AU3745599A (en) | Noncloning technique for expressing a gene of interest | |
AU5800696A (en) | Rhesus ob protein and dna | |
AU6585498A (en) | Novel uncoupling protein and methods of use | |
AU4992299A (en) | Uncoupling protein 4 (ucp-4) and methods of use | |
AU5038498A (en) | Mass production and long-term preservation of fungivorous nematodes and uses thereof | |
AU1795400A (en) | Expression vectors comprising multiple shear stress responsive elements (ssre) and a gene of interest and methods of use thereof | |
AU1313999A (en) | Method of providing and retrieving a data segment | |
GB9708526D0 (en) | Eukaryotic gene expression cassette and uses thereof | |
AU4397797A (en) | Method of gene introduction | |
AU9001898A (en) | Beta-fructofuranosidase and gene thereof | |
AU5170896A (en) | Seca gene of mycobacterium tuberculosis and related methods and compositions | |
AU1309000A (en) | A hydroperoxide lyase gene from maize and methods of use | |
AU6833996A (en) | Identification of bases in nucleic acid sequences | |
AU4994596A (en) | Interdependent adenoviral vectors and methods of using same | |
AU2545992A (en) | Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them, and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase | ||
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |